These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia. López-Karpovitch X, Cárdenas R, Piedras J. Rev Invest Clin; 1997 Jun; 49(1):31-6. PubMed ID: 9229753 [Abstract] [Full Text] [Related]
3. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings. Khalidi HS, Brynes RK, Medeiros LJ, Chang KL, Slovak ML, Snyder DS, Arber DA. Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654 [Abstract] [Full Text] [Related]
4. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype. Mesárosová A, Hrivnáková A, Klobusická M, Babusíková O. Neoplasma; 1995 Dec; 42(1):9-14. PubMed ID: 7617076 [Abstract] [Full Text] [Related]
5. [Immunophenotypes on blast cells of chronic myelogenous leukemia]. Motoji T. Nihon Rinsho; 2001 Dec; 59(12):2342-7. PubMed ID: 11766336 [Abstract] [Full Text] [Related]
6. [Immunophenotype of blast crisis in chronic myeloid leukemia]. Favre G, Passweg J, Hoffmann T, Speck B, Gratwohl A, Tichelli A. Schweiz Med Wochenschr; 1998 Oct 17; 128(42):1624-6. PubMed ID: 9824896 [Abstract] [Full Text] [Related]
7. The onset of CML in blastic crisis: molecular features. Gregorini A, Filippetti A, Luchetti F, Walker A, Lillington DM, Papa S, Valentini M. J Biol Regul Homeost Agents; 1997 Oct 17; 11(3):111-4. PubMed ID: 9498160 [Abstract] [Full Text] [Related]
8. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML]. Liu YL, Wang XN, Liu HS. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun 17; 22(3):629-33. PubMed ID: 24989266 [Abstract] [Full Text] [Related]
9. Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. Leone G, La Rocca LM, Teofili L, De Candia E, Landolfi R, Sica S, Zini G, Zollino M, Tabilio A. Haematologica; 1992 Jun 17; 77(4):311-4. PubMed ID: 1427440 [Abstract] [Full Text] [Related]
10. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia. Anand M, Ghara N, Kumar R, Singh S, Sengar M, Panikar N, Raina V, Sharma A. Ann Hematol; 2005 Nov 17; 84(12):767-70. PubMed ID: 15990995 [Abstract] [Full Text] [Related]
11. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire]. Inwoley KA, Sawadogo D, Mizero L, Salou M, Karim N, Sangaré A. Bull Soc Pathol Exot; 2004 Nov 17; 97(5):319-22. PubMed ID: 15787262 [Abstract] [Full Text] [Related]
12. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors. Shimoda K, Okamura S, Harada N, Ikematsu W, Kondo S, Kawasaki C, Tanaka T, Etou T, Akashi K, Okamura T. Cancer Res; 1992 Jun 01; 52(11):3052-5. PubMed ID: 1534271 [Abstract] [Full Text] [Related]
13. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia. Babusíková O, Glasová M, Koníková E, Kusenda J. Neoplasma; 1996 Jun 01; 43(6):367-72. PubMed ID: 8996560 [Abstract] [Full Text] [Related]
14. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma. Kroschinsky F, Friedrich K, Hanel M, Mohr B, Langer T, Meinhardt M, Thiede C, Bornhauser M, Baretton G, Ehninger G. Ann Hematol; 2003 Jan 01; 82(1):47-52. PubMed ID: 12574966 [Abstract] [Full Text] [Related]
15. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y. Ai Zheng; 2007 Apr 01; 26(4):418-22. PubMed ID: 17430665 [Abstract] [Full Text] [Related]
16. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up. Lahaye T, Riehm B, Berger U, Paschka P, Müller MC, Kreil S, Merx K, Schwindel U, Schoch C, Hehlmann R, Hochhaus A. Cancer; 2005 Apr 15; 103(8):1659-69. PubMed ID: 15747376 [Abstract] [Full Text] [Related]
17. [A "primitive" variant of the blast crisis in chronic myeloleukemia]. Baryshnikov AIu, Turkina AG, Moiseenkova IN, Frolova EA, Sediakhina NP, Diagileva OA, Khoroshko ND, Mokeeva RA. Ter Arkh; 1995 Apr 15; 67(7):22-5. PubMed ID: 7482298 [Abstract] [Full Text] [Related]
18. [T lymphoblastic leukemia with leukemoid reaction or the extramedullary blast crisis of Philadelphia chromosome-negative chronic myeloid leukemia? Comments apropos 2 cases]. Tassies D, Feliu E, Villamor N, Urbano-Ispizua A, Cervantes F, Campo E, Ordi J, Vernet M, Pujol R, López R. Med Clin (Barc); 1990 Nov 10; 95(16):618-20. PubMed ID: 2097454 [Abstract] [Full Text] [Related]
20. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset. Fukuno K, Tsurumi H, Yamada T, Oyama M, Matsuyama T, Terakura S, Kodera Y, Moriwaki H. Bone Marrow Transplant; 2003 Feb 10; 31(3):211-3. PubMed ID: 12621483 [Abstract] [Full Text] [Related] Page: [Next] [New Search]